PolyU ULS

18/06/2026

理大於最新公布的QS 2027年世界大學排名穩步上揚，升至全球第50位，刷新歷年最佳排名，印證理大在學術成就、科研創新及整體辦學實力方面獲國際權威機構高度肯定，國際高等教育地位持續提升。

理大校董會主席林大輝博士表示：「理大按照發展藍圖，循序漸進，一步一腳印、穩健前行，今日成功躋身全球50強大學，達成發展歷程中的重要階段性目標。從長遠發展而言，香港正籌劃首個五年規劃，我們希望北都大學城能為理大提供充足的土地及發展空間，為大學未來拓展奠定更堅實的基礎和更有利條件。」

理大校長滕錦光教授表示：「理大將更好融入和服務國家發展大局，充分發揮自身獨特優勢，以教育、科技、人才一體化發展為核心方向，並依托目前大學在中國內地 12 個城市佈局的技術創新研究院網絡，精準對接各地產業發展需求，實現產學研深度融合的格局，為國家建設、高質量發展以及科技強國建設作出更大貢獻。」

更多：https://polyu.hk/NbGNO

PolyU has steadily risen to 50th place globally in the latest QS World University Rankings 2027, marking a record-high position for the University. The milestone reflects strong international recognition of PolyU’s academic excellence, research and innovation capabilities, and overall institutional strength, further elevating its standing in the global higher education landscape.

“PolyU has progressed in a consistent and steady manner in accordance with its development blueprint, moving forward pragmatically and purposefully. Today, the University has successfully joined the ranks of the world’s top 50 universities, reaching an important milestone in its development journey. From a long-term development perspective, Hong Kong is formulating its first Five-Year Plan, and we hope that the Northern Metropolis University Town will provide PolyU with sufficient land and development space, laying a stronger foundation and creating more favourable conditions for the University’s future expansion,” said Dr LAM Tai-fai, PolyU Council Chairman.

“Looking ahead, PolyU will further integrate into and serve the Nation’s overall development strategy, fully leveraging the University’s unique strengths. With the integrated development of education, technology and talents as our core focus, and building on our existing network of translational research institutes across 12 cities in the Chinese Mainland, we will respond to local industrial and societal needs and deepen industry-academia-research collaboration, thereby making greater contributions to national development, high-quality growth and the building of the Nation into a global science and technology powerhouse,” said Prof. Jin-Guang TENG, President of PolyU.

More: https://polyu.hk/hqbzH

#香港理工大學 #世界大學排名 #理大排名

16/06/2026

12/06/2026

🌟 理大學生癌症研究於創新及創業大賽勇奪殊榮 🌟

理大應用生物及化學科技學系博士研究生梁泳希和李孟靈博士，在「第十二屆香港大學生創新及創業大賽」中表現卓越。

他們憑藉研究項目「用於實體腫瘤的新型勝肽鏈結嵌合抗原受體巨噬細胞」，囊括「創新類別特等獎」以及「生命科學一等奬」。

在副系主任及教授李建華教授、和助理教授王搢珽教授的指導下，團隊首創以「胜肽連接系統」改造巨噬細胞，取代傳統T細胞，為治療實體腫瘤提供嶄新方案。該平台適用於 92% 的惡性腫瘤，並兼具更快捷、安全性佳及可實現個人化治療，極具市場潛力。

👏 恭喜兩位年輕科研人才取得傑出成就！

🌟 PolyU students’ cancer research achieves top honours in innovation and life sciences 🌟

Miss Rainbow Leung Wing Hei (PhD student) and Dr. Martina Lei Mang Leng (graduate) from PolyU’s Department of Applied Biology and Chemical Technology delivered an exceptional performance at the 12th Hong Kong University Student Innovation and Entrepreneurship Competition.

With their groundbreaking project, “Therapeutic efficacy of peptide-linked chimeric antigen receptor macrophages (pCAR-M) in solid tumors,” the team won the Grand Prize in the Innovation category and the First Prize in the Life Sciences category.

Supervised by Prof. Terence Lee Kin‑wah, Associate Head and Professor, and Prof. Clarence Wong Tsun‑ting, Assistant Professor of the same department, the project pioneers a peptide‑linked system to engineer macrophages instead of T cells, offering a novel approach to treating solid tumours. The pCAR‑M platform is faster, safer, and more accessible, with potential applicability to 92% of malignant tumours, unlocking vast opportunities in the solid-tumour market.

👏 Congratulations to our young innovators for their remarkable achievement!

Learn more 更多
https://polyu.hk/oTpNm

06/05/2026

Thank you very much for your participation in the ULS survey for 2025. The following participants have been randomly selected to each receive 2 hours of free equipment usage in May 2026 for their laboratories:

Manyin WU
Elena BOLONOVA
Xiaohui ZHANG
Jordy Evan SULAIMAN
Chiu Tsun Philip TANG
Boxin ZHENG
Hong HU
Yao LU
Hongjin LAN
Jianyun XIONG
Kit Ying CHOY
Xiaobo LIU
Yuexin SONG
Man Ka CHAN
Feng PAN
Wing Hei LEUNG
Wing Leung WONG
Sze Wan SHAN
Yidi WANG
Qiwen LIAO

04/05/2026

12/03/2026

【理大研發全聲學腦機接口系統 有望為柏金遜症提供高效新療法✨】

隨着人口老化，柏金遜症等常見長者疾病愈見普遍。現時的治療方法多依賴藥物或外科手術。理大無創腦機接口研究中心主任、生物醫學工程學系教授孫雷教授與其學系博士畢業生丘志海教授帶領科研團隊研發新一代「全聲學腦機接口系統」，運用「經顱超聲神經調控技術」，以超聲波實現完全無創、深腦穿透和高精度的神經調控，可望為柏金遜症以至抑鬱症等神經及精神疾病患者，帶來嶄新治療方案。💡

團隊已透過小鼠實驗驗證技術成效。下一階段，團隊將擴充臨床實驗的規模，計劃聯合中國內地共五間頂級醫療中心，招募100名柏金遜症患者開展臨床研究，驗證其超聲波技術的安全與療效。🏥未來，團隊亦期望與香港的醫院合作進行臨床研究，並研發更輕便的家用醫療裝置，讓患者日後可在家中進行持續治療。💪

更多：https://polyu.hk/SFKqt

【PolyU all-acoustics brain-computer interface system forges new paths for Parkinson’s disease therapy✨】

An ageing population is often accompanied by an increase in age‑related disorders such as Parkinson’s disease, an incurable neurodegenerative disorder that impairs body movement and which is mainly alleviated by medicines or surgical procedures.
A research team led by Prof. Sun Lei, Director of the Research Centre for Non-invasive Brain Computer Interface and Prof. Qiu Zhihai, a PhD graduate and Professor of the Department of Biomedical Engineering at PolyU, has developed the next‑generation “All‑Acoustics Brain‑Computer Interface (BCI) System”, leveraging “transcranial ultrasound neuromodulation” to deliver fully non‑invasive, deep‑brain and high‑precision neural modulation with ultrasound. The system presents a promising new therapeutic approach for treating Parkinson’s disease, as well as other neurological and psychiatric disorders. 💡

The team has validated the technology’s efficacy through animal studies. In the next stage, Prof. Sun will expand the scale of clinical validation. He plans to collaborate with five leading medical centres in China to conduct a clinical study involving 100 Parkinson’s disease patients and systematically assess the ultrasound technique’s safety and efficacy, paving the way for regulatory approval and commercialisation. 🏥 Looking ahead, the team also aims to partner with Hong Kong hospitals for clinical study and develop a more portable household version of the system, enabling patients to receive continuous treatment at home. 💪

More: https://polyu.hk/FxesE

#香港理工大學 #理大科研 #腦機接口 #柏金遜症治療

09/03/2026

ULS Workshop - Exploring the STELLARIS 8 FALCON Confocal Platform from Leica

The University Research Facility in Life Sciences (ULS) is co-organizing a workshop on advanced confocal and functional imaging with Leica. This workshop will focus on the STELLARIS 8 FALCON, a next-generation platform that integrates high-speed lifetime imaging with a fully tunable white light laser to push the boundaries of conventional confocal microscopy. On-site imaging advice will be provided by Application Specialists from Leica Microsystems.

Key Specifications:

White Light Laser: Fully tunable excitation (405nm, 440–790nm)
High-Sensitivity Detection: 5 detectors (HyD S, HyD X, and HyD R) for optimized photon counting
FALCON & LIGHTNING: Fast lifetime imaging and super-resolution (120nm XY, 200nm Z)
High-Speed Imaging: 22 mm FOV scanner with 10 ps temporal resolution
Recommended Applications:

Advanced Multiplexing: Precise excitation of multiple fluorophores with minimal crosstalk
Functional Imaging:Monitor metabolic states, pH changes, and protein-protein interactions (FLIM-FRET) via TauSense and FALCON
Deep Tissue with High Resolution: Perform high-resolution 3D imaging of thick specimens with LIGHTNING and specialized HyD detectors.
The details of the upcoming workshop are as follow:

Date and Time: 11 March, 2026 (3 sessions)
1. 2:30 pm – 3:30pm
2. 3:30 pm – 4:30pm
3. 4:30 pm – 5:30pm

Venue: Y210

Note: Workshops are filled on a first-come, first-served basis. You are highly encouraged to bring your sample to the Demo sessions.

For registration or enquiries, please contact Dr. Idy Ho ([email protected]).

All are welcome! Thank you for your attention.

04/02/2026

【理大研發新型抗體針對脂肪細胞蛋白 為代謝相關肝癌治療帶來新方向】

肝癌是全球三大最致命癌症之一，而「脂肪肝」近年亦愈見普遍。由理大應用生物及化學科技學系副系主任及教授李建華教授及其研究團隊發現了一種由脂肪細胞分泌、能促進腫瘤生長的蛋白質，並成功研發可中和該蛋白質的新型抗體，在抑制肝癌進展方面取得重要進展。隨著這項基於脂肪細胞分泌物的免疫方案日漸成熟，未來有望為「脂肪肝」病患者帶來更多治療選擇。

更多：https://polyu.hk/HQnGA

【PolyU develops novel antibody targeting fat cell protein, offering new approach to treating metabolism-related liver cancer】

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become increasingly common in recent years. A research team led by Prof. Terence LEE, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology has identified an adipocyte-derived protein that promotes cancer growth and has successfully developed a novel antibody that neutralises this protein, marking a significant breakthrough in impeding the progression of liver cancer. The team believes that, as this adipocyte-targeted immunotherapy continues to mature, it will bring more treatment options to MASLD patients.

More: https://polyu.hk/fAkza

#香港理工大學 #理大科研 #肝癌 #免疫療法

17/12/2025

The University Research Facility in Life Sciences (ULS) has recently acquired the CytoFLEX S flow cytometer, which enables both conventional and spectral flow cytometry.
https://www.polyu.edu.hk/uls/equipment-and-service/cell-and-molecular-biology/beckman-coulter-cytoflex-s-flow-cytometer/

This system combines the conventional flow cytometer, the CytoFLEX S flow cytometer, and the spectral flow cytometer, the CytoFLEX Mosaic 63 Spectral Detection Module. It allows switching between true conventional and spectral modes. The CytoFLEX S conventional flow cytometer has 4 active lasers (405 nm, 488 nm, 561 nm, 638 nm) and 13 channels for fluorescence detection. The Mosaic 63 Spectral Detection Module enables spectral capabilities and offers 1 FSC channel, 4 SSC channels, and 58 fluorescent channels, for a total of 63 channels of detection. Both conventional and spectral modules offer superior fluorescence sensitivity for dim and complex multicolour staining and can detect nanoparticles as small as 80 nm.

The CytoFLEX S flow cytometer with Mosaic 63 Spectral Detection Module is combined of the conventional flow cytometer, the CytoFLEX S and the spectral flow cytometer, the Mosaic 63 Spectral Detection Module. It allows seamless switching between true conventional and spectral modes. The CytoFLEX mosa...